Wuhan Fuxing Bio-Pharmaceutical Co., Ltd. is a holding subsidiary of China's top 500 private enterprises Fuxing Group, which is a modern high-tech enterprise integrating drug research and development, production and sales on the basis of the acquisition of the original "Hanchuan Pharmaceutical Factory" in July 2001. Over the years, the company adheres to the concept of "committed to people's health and longevity, improve the quality of human life", and strictly implements the concept of "starting from prevention to control product quality, and creating safety and effectiveness with standard details; With the quality policy of continuous improvement to ensure quality leadership and do high-quality drugs to serve people's health, we ensure the safety and effectiveness of drugs for the general public. The company has been rated as China's pharmaceutical quality and integrity "double excellent" enterprises, "China's pharmaceutical growth Top 50 enterprises", Hubei Province "specialized special new" small giant enterprise, "Hubei Province pillar industry segmentation field hidden champion cultivation" enterprises.